HUE066903T2 - Argináz inhibitorok és eljárások alkalmazásukra - Google Patents

Argináz inhibitorok és eljárások alkalmazásukra

Info

Publication number
HUE066903T2
HUE066903T2 HUE19758683A HUE19758683A HUE066903T2 HU E066903 T2 HUE066903 T2 HU E066903T2 HU E19758683 A HUE19758683 A HU E19758683A HU E19758683 A HUE19758683 A HU E19758683A HU E066903 T2 HUE066903 T2 HU E066903T2
Authority
HU
Hungary
Prior art keywords
methods
arginase inhibitors
arginase
inhibitors
Prior art date
Application number
HUE19758683A
Other languages
English (en)
Hungarian (hu)
Inventor
Dedong Wu
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HUE066903T2 publication Critical patent/HUE066903T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/22Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE19758683A 2018-08-22 2019-08-21 Argináz inhibitorok és eljárások alkalmazásukra HUE066903T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862721113P 2018-08-22 2018-08-22

Publications (1)

Publication Number Publication Date
HUE066903T2 true HUE066903T2 (hu) 2024-09-28

Family

ID=67742403

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE19758683A HUE066903T2 (hu) 2018-08-22 2019-08-21 Argináz inhibitorok és eljárások alkalmazásukra

Country Status (25)

Country Link
US (1) US11952392B2 (https=)
EP (2) EP4371614A3 (https=)
JP (1) JP7441210B2 (https=)
KR (1) KR102668252B1 (https=)
CN (1) CN112584900B (https=)
AU (1) AU2019323663B2 (https=)
CA (1) CA3109100A1 (https=)
CL (1) CL2021000430A1 (https=)
DK (1) DK3840837T3 (https=)
EA (1) EA202190532A1 (https=)
ES (1) ES2980252T3 (https=)
FI (1) FI3840837T3 (https=)
HR (1) HRP20240694T1 (https=)
HU (1) HUE066903T2 (https=)
IL (1) IL280924B2 (https=)
LT (1) LT3840837T (https=)
MA (1) MA53427B1 (https=)
MX (1) MX2021002042A (https=)
PL (1) PL3840837T3 (https=)
PT (1) PT3840837T (https=)
RS (1) RS65608B1 (https=)
SG (1) SG11202101618PA (https=)
SI (1) SI3840837T1 (https=)
SM (1) SMT202400221T1 (https=)
WO (1) WO2020038983A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI877770B (zh) 2018-02-27 2025-03-21 美商英塞特公司 作為a2a / a2b抑制劑之咪唑并嘧啶及三唑并嘧啶
EP3810610A1 (en) 2018-05-18 2021-04-28 Incyte Corporation Fused pyrimidine derivatives as a2a / a2b inhibitors
WO2020010197A1 (en) 2018-07-05 2020-01-09 Incyte Corporation Fused pyrazine derivatives as a2a / a2b inhibitors
TWI829857B (zh) 2019-01-29 2024-01-21 美商英塞特公司 作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶
PH12021551902A1 (en) * 2019-02-08 2022-08-01 Astrazeneca Ab Arginase inhibitors and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201503168VA (en) * 2010-04-22 2015-06-29 Mars Inc Inhibitors of arginase and their therapeutic applications
US10143699B2 (en) * 2015-06-23 2018-12-04 Calithera Biosciences, Inc. Compositions and methods for inhibiting arginase activity
JP2020502259A (ja) * 2016-11-08 2020-01-23 カリセラ バイオサイエンシズ,インコーポレイテッド アルギナーゼ阻害剤併用療法
CN114989205A (zh) 2016-12-22 2022-09-02 卡里塞拉生物科学股份公司 用于抑制精氨酸酶活性的组合物和方法
CN117186134A (zh) 2018-02-17 2023-12-08 阿斯利康(瑞典)有限公司 精氨酸酶抑制剂及其使用方法
EP3765006A4 (en) 2018-03-13 2022-02-23 Merck Sharp & Dohme Corp. ARGINASE INHIBITORS AND METHODS OF USE
CN111770756B (zh) 2018-04-27 2023-03-31 四川科伦博泰生物医药股份有限公司 非天然氨基酸类衍生物、包含其的药物组合物及其制备方法和用途

Also Published As

Publication number Publication date
KR102668252B1 (ko) 2024-05-21
CL2021000430A1 (es) 2021-09-03
EP4371614A2 (en) 2024-05-22
JP2021535111A (ja) 2021-12-16
EP3840837B1 (en) 2024-03-20
MA53427B1 (fr) 2024-06-28
KR20210049120A (ko) 2021-05-04
AU2019323663B2 (en) 2022-07-14
MX2021002042A (es) 2021-04-28
SMT202400221T1 (it) 2024-07-09
IL280924B1 (en) 2024-06-01
PL3840837T3 (pl) 2024-08-19
IL280924B2 (en) 2024-10-01
IL280924A (en) 2021-04-29
US20210332068A1 (en) 2021-10-28
ES2980252T3 (es) 2024-09-30
PT3840837T (pt) 2024-06-14
FI3840837T3 (fi) 2024-06-03
SG11202101618PA (en) 2021-03-30
US11952392B2 (en) 2024-04-09
JP7441210B2 (ja) 2024-02-29
EP4371614A3 (en) 2025-09-24
CN112584900A (zh) 2021-03-30
AU2019323663A1 (en) 2021-04-08
EP3840837A1 (en) 2021-06-30
WO2020038983A1 (en) 2020-02-27
SI3840837T1 (sl) 2024-07-31
RS65608B1 (sr) 2024-07-31
LT3840837T (lt) 2024-06-10
CA3109100A1 (en) 2020-02-27
HRP20240694T1 (hr) 2024-08-16
MA53427A (fr) 2021-12-01
EA202190532A1 (ru) 2021-07-08
CN112584900B (zh) 2025-07-15
DK3840837T3 (da) 2024-06-10

Similar Documents

Publication Publication Date Title
HUE057632T2 (hu) KRAS G12C inhibitorok és eljárások alkalmazásukra
IL282487A (en) Tyk2 inhibitors and uses thereof
EP4043917C0 (en) DETECTION METHOD AND DEVICE
EP3761992A4 (en) ARGINASE INHIBITORS
IL282090A (en) Tyk2 inhibitors and uses thereof
IL287751A (en) Kcnt1 inhibitors and methods of use
IL287768A (en) Kcnt1 inhibitors and methods of use
HUE052468T2 (hu) Arginázgátlók és terápiás alkalmazásaik
ZA202407941B (en) Arginase inhibitors and methods of use thereof
HUE054272T2 (hu) Összetételek és módszerek az argináz-tevékenység gátlásához
IL286248A (en) Tyk2 inhibitors and uses thereof
HUE061841T2 (hu) Anti-sortilin antitestek és felhasználásuk módszerei
HUE066903T2 (hu) Argináz inhibitorok és eljárások alkalmazásukra
HUE063120T2 (hu) LRRC33-inhibitorok és alkalmazásuk
IL283782A (en) Anellosomes and methods of use
DK3677278T3 (da) Isoformselektive tgfbeta1-inhibitorer og anvendelse deraf
IL290492A (en) Methods to detect mtbr tau isoforms and use thereof
DK3543240T3 (da) URAT1-inhibitor og anvendelse deraf
IL284475A (en) Multiplexed assay and methods of use thereof
DK3532459T3 (da) Lsd1-hæmmere og medicinske anvendelser deraf
DK3796979T3 (da) Mir-181-hæmmere og anvendelser deraf
IL286485A (en) Pi4-kinase inhibitors and methods of using the same
EP3353150A4 (en) INHIBITORS OF ALK AND SRPK AND METHOD OF USE
HUE060654T2 (hu) Heterokondelzált piridonvegyületek és azok IDH-gátlóként történõ alkalmazása
DK3724196T3 (da) Substituerede azetidindihydrothienopyridiner og anvendelse deraf som phosphodiesterasehæmmere